The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open label, single arm, prospective phase II study to evaluate the efficacy and safety of bevacizumab with gemcitabine and carboplatin as first-line treatment for metastatic triple negative breast cancer patients.
 
Sudeep Gupta
Research Funding - Amgen (Inst); Celltrion (Inst); Johnson & Johnson (Inst); Novartis (Inst); Oncostem Diagnostics (Inst); Roche (Inst); Sanofi (Inst)
 
Govind K. Babu
No Relationships to Disclose
 
Raju Titus Chacko
No Relationships to Disclose
 
Dinesh Doval
No Relationships to Disclose
 
Chirag Desai
Honoraria - Roche India
 
Nalini Kilara
No Relationships to Disclose
 
Shona Milon Nag
No Relationships to Disclose
 
Chirag A. Shah
No Relationships to Disclose
 
SVS Deo
No Relationships to Disclose
 
Smruti B. Koppikar
Honoraria - Roche India
Speakers' Bureau - Roche India
 
Binay Swarup
Employment - Roche India
 
Anil Arjundas Kukreja
Employment - Roche India
 
Vinod Raina
No Relationships to Disclose